[Target of herpes virus growth inhibitors].
Nishiyama
H
H
D000470:Alkaloids / Q000494:pharmacology*; D000818:Animals; D016590:Aphidicolin; D004264:DNA Topoisomerases, Type I / Q000378:metabolism; D004259:DNA-Directed DNA Polymerase / Q000378:metabolism; D004224:Diterpenes / Q000494:pharmacology*; D006147:Guanine / Q000031:analogs & derivatives* / Q000494:pharmacology; D006564:Herpesviridae / Q000187:drug effects* / Q000254:growth & development; D007612:Kanamycin / Q000494:pharmacology*; D010746:Phosphonoacetic Acid / Q000494:pharmacology*; D011453:Prostaglandins / Q000494:pharmacology*
D000470:Alkaloids; D004224:Diterpenes; D011453:Prostaglandins; C057479:oxetanocin G; D016590:Aphidicolin; D007612:Kanamycin; D006147:Guanine; C062044:citrusinine I; D004259:DNA-Directed DNA Polymerase; D004264:DNA Topoisomerases, Type I; D010746:Phosphonoacetic Acid